Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

DEBUGGING-LPS

Financiado

Deciphering and Exploiting the chemical features of Silent Lipopolysaccharides:...

Deciphering and Exploiting the chemical features of Silent Lipopolysaccharides: a gift from gut microbiota Gut Microbiota is a key actor for human health, driving many physiological and pathological processes, including immune system development and modulation. How this massive population of microorganisms, most of which are bacteria,... ver más

30/09/2027

UNINA

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 1 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-03-08

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2021-STG: ERC STARTING GRANTS

I+D

Cerrada hace 3 años

0% 100%

1 Participantes

UNINA

1.95M€ | Lider

Proyectos interesantes

BIO2013-47198-P ESTUDIO MOLECULAR DE GLICOESTRUCTURAS PRESENTES EN LA SUPERF... 151K€ Cerrado

WePredict Microbiota and immune responses at weaning predict the susce... 2M€ Cerrado

SAF2010-16755 FUNCION DE LA INMUNIDAD INNATA EN LA TOLERANCIA INTESTINAL:... 133K€ Cerrado

MICROINVADER Molecular mechanisms of bacterial invasion and colonization... 196K€ Cerrado

JCI-2009-05816 INTERACCIONES DE LOS MICROORGANISMOS PROBIOTICOS Y DE LA MIC... 101K€ Cerrado

BES-2013-065587 FUNCION DE VESICULAS DE MEMBRANA EXTERNA DE MICROBIOTA COMEN... 84K€ Cerrado

Últimas noticias

25-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 52 concesiones

25-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 1 concesiones

25-11-2024: FUNDACION-EOI En las últimas 48 horas el Organismo FUNDACION EOI ha otorgado 6 concesiones

Duración del proyecto: 66 meses Fecha Inicio: 2022-03-08
Fecha Fin: 2027-09-30

Líder del proyecto

UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II

TRL 4-5

Presupuesto del proyecto 2M€

Descripción del proyecto Gut Microbiota is a key actor for human health, driving many physiological and pathological processes, including immune system development and modulation. How this massive population of microorganisms, most of which are bacteria, establishes commensal, mutualistic or pathogenic interactions with the human host despite the vigilance of the immune system, is still obscure and requires an in-depth study. The story gets more intricate considering that gut is home for a myriad of Gram-negative bacteria whose outer membrane main constituent is the lipopolysaccharide (LPS). Due to its chemical structure, LPS is considered a potent elicitor of immune inflammatory reactions in mammals, being usually associated to perilous bacteria and detrimental outcomes for human health. Nevertheless, LPS also decorates the membrane of harmless and beneficial Gram-negatives of gut microbiota. How LPS is tolerated and remains (apparently) silent in the gut is a major unsolved question representing a frontier in our understanding of innate immunity. DEBUGGING-LPS project will contribute to answer this question, starting from the assumption that the chemistry of LPS is the real message taken from human host of the bacterial interaction, either beneficial or harmful. Strategically based on my expertise in organic chemistry, and integrating synthetic chemistry and cellular immunology studies, DEBUGGING-LPS will decrypt the 'chemical language' spoken by LPS in the gut. This project will deliver a clear picture of the chemistry at the basis of the difference between 'good' and 'bad' LPS, providing tools for the exploitation of the acquired knowledge to create novel therapeutics for resolving/mitigating immune disorders. DEBUGGING-LPS has been conceived to go beyond the state-of-the-art, breaking the dogma of LPS as an enemy, leaving space for a new vision of this glycomolecule: i.e. no longer as a toxic bacterial product rather as an immune signal vital for the proper functioning of our body.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores